Click here to get full coverage on HCW Biologics (HCWB) files exhibits-only S-1 amendment with new exhibits - Stock Titan

HCW Biologics (HCWB) files exhibits-only S-1 amendment with new exhibits  Stock Titan

HCW Biologics (HCWB) files exhibits-only S-1 amendment with new exhibits - Stock Titan

Click here to get full coverage on HCW Biologics (HCWB) Stock Price, News & Analysis - MarketBeat

HCW Biologics (HCWB) Stock Price, News & Analysis  MarketBeat

HCW Biologics (HCWB) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on What's Going On With HCW Biologics Stock Tuesday? - HCW Biologics (NASDAQ:HCWB) - Benzinga

What's Going On With HCW Biologics Stock Tuesday? - HCW Biologics (NASDAQ:HCWB)  Benzinga

What's Going On With HCW Biologics Stock Tuesday? - HCW Biologics (NASDAQ:HCWB) - Benzinga

Click here to get full coverage on HCWB: Shareholders approved all proposals as clinical and financial milestones were highlighted - TradingView

HCWB: Shareholders approved all proposals as clinical and financial milestones were highlighted  TradingView

HCWB: Shareholders approved all proposals as clinical and financial milestones were highlighted - TradingView

Click here to get full coverage on HCW Biologics (HCWB) AGM 2025 Summary - Quartr

HCW Biologics (HCWB) AGM 2025 Summary  Quartr

HCW Biologics (HCWB) AGM 2025 Summary - Quartr

Click here to get full coverage on HCW Biologics Announces Positive Results for Preliminary - GlobeNewswire

HCW Biologics Announces Positive Results for Preliminary  GlobeNewswire

HCW Biologics Announces Positive Results for Preliminary - GlobeNewswire

Click here to get full coverage on $HCWB stock is down 14% today. Here's what we see in our data. - Quiver Quantitative

$HCWB stock is down 14% today. Here's what we see in our data.  Quiver Quantitative

$HCWB stock is down 14% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on HCW Biologics Shareholders Approve Governance and Capital Measures - The Globe and Mail

HCW Biologics Shareholders Approve Governance and Capital Measures  The Globe and Mail

HCW Biologics Shareholders Approve Governance and Capital Measures - The Globe and Mail

Click here to get full coverage on Shareholders back HCW Biologics (NASDAQ: HCWB) 2026 board slate - Stock Titan

Shareholders back HCW Biologics (NASDAQ: HCWB) 2026 board slate  Stock Titan

Shareholders back HCW Biologics (NASDAQ: HCWB) 2026 board slate - Stock Titan

Click here to get full coverage on HCW Biologics (HCWB) spikes 71% as micro-cap volatility returns after Nasdaq compliance and recent financing - Quiver Quantitative

HCW Biologics (HCWB) spikes 71% as micro-cap volatility returns after Nasdaq compliance and recent financing  Quiver Quantitative

HCW Biologics (HCWB) spikes 71% as micro-cap volatility returns after Nasdaq compliance and recent financing - Quiver Quantitative

Click here to get full coverage on New alopecia drug from HCW Biologics shows early test gains - Stock Titan

New alopecia drug from HCW Biologics shows early test gains  Stock Titan

New alopecia drug from HCW Biologics shows early test gains - Stock Titan

Click here to get full coverage on HCW Biologics (HCWB) CEO boosts stake with stock and warrant buys - Stock Titan

HCW Biologics (HCWB) CEO boosts stake with stock and warrant buys  Stock Titan

HCW Biologics (HCWB) CEO boosts stake with stock and warrant buys - Stock Titan

Click here to get full coverage on HCW Biologics (HCWB) granted Nasdaq extension to fix $1 bid price deficiency - Stock Titan

HCW Biologics (HCWB) granted Nasdaq extension to fix $1 bid price deficiency  Stock Titan

HCW Biologics (HCWB) granted Nasdaq extension to fix $1 bid price deficiency - Stock Titan

Click here to get full coverage on HCW Biologics reclaims CAR-T tool that may cut production costs - Stock Titan

HCW Biologics reclaims CAR-T tool that may cut production costs  Stock Titan

HCW Biologics reclaims CAR-T tool that may cut production costs - Stock Titan

Click here to get full coverage on Pancreatic cancer candidate shrank tumors in animals; human filing next - Stock Titan

Pancreatic cancer candidate shrank tumors in animals; human filing next  Stock Titan

Pancreatic cancer candidate shrank tumors in animals; human filing next - Stock Titan

Click here to get full coverage on Alopecia trial drug shows no dose limits as HCW Biologics posts Q1 profit - Stock Titan

Alopecia trial drug shows no dose limits as HCW Biologics posts Q1 profit  Stock Titan

Alopecia trial drug shows no dose limits as HCW Biologics posts Q1 profit - Stock Titan

Click here to get full coverage on HCW Biologics (HCWB) files S-1 for resale of 5.69M PIPE shares and warrants - Stock Titan

HCW Biologics (HCWB) files S-1 for resale of 5.69M PIPE shares and warrants  Stock Titan

HCW Biologics (HCWB) files S-1 for resale of 5.69M PIPE shares and warrants - Stock Titan

Click here to get full coverage on Biotech HCW Biologics plans $4M share sale to fund trials and cut debt - Stock Titan

Biotech HCW Biologics plans $4M share sale to fund trials and cut debt  Stock Titan

Biotech HCW Biologics plans $4M share sale to fund trials and cut debt - Stock Titan

Click here to get full coverage on HCW Biologics CFO buys shares and warrants | HCWB Insider Trading - Stock Titan

HCW Biologics CFO buys shares and warrants | HCWB Insider Trading  Stock Titan

HCW Biologics CFO buys shares and warrants | HCWB Insider Trading - Stock Titan

Click here to get full coverage on HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy - Stocktwits

HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy  Stocktwits

HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy - Stocktwits

Click here to get full coverage on HCWB Stock Explodes As Earnings Swing Fuels Biotech Rally - StocksToTrade

HCWB Stock Explodes As Earnings Swing Fuels Biotech Rally  StocksToTrade

HCWB Stock Explodes As Earnings Swing Fuels Biotech Rally - StocksToTrade

Click here to get full coverage on HCW Biologics (NASDAQ: HCWB) turns Q1 2026 profit amid serious going concern warning - Stock Titan

HCW Biologics (NASDAQ: HCWB) turns Q1 2026 profit amid serious going concern warning  Stock Titan

HCW Biologics (NASDAQ: HCWB) turns Q1 2026 profit amid serious going concern warning - Stock Titan

Click here to get full coverage on New fusion immunotherapy deal brings HCW Biologics $7M upfront - Stock Titan

New fusion immunotherapy deal brings HCW Biologics $7M upfront  Stock Titan

New fusion immunotherapy deal brings HCW Biologics $7M upfront - Stock Titan

Click here to get full coverage on Armistice Capital and Steven Boyd report 4.99% stake in HCWB (HCWB) - Stock Titan

Armistice Capital and Steven Boyd report 4.99% stake in HCWB (HCWB)  Stock Titan

Armistice Capital and Steven Boyd report 4.99% stake in HCWB (HCWB) - Stock Titan

Click here to get full coverage on Clark Hill Advises HCW Biologics in $4.0 Million PIPE Offering | News & Events | Clark Hill PLC - Clark Hill

Clark Hill Advises HCW Biologics in $4.0 Million PIPE Offering | News & Events | Clark Hill PLC  Clark Hill

Clark Hill Advises HCW Biologics in $4.0 Million PIPE Offering | News & Events | Clark Hill PLC - Clark Hill

Click here to get full coverage on HCW Biologics (HCWB) director adds common shares and long-dated warrants - Stock Titan

HCW Biologics (HCWB) director adds common shares and long-dated warrants  Stock Titan

HCW Biologics (HCWB) director adds common shares and long-dated warrants - Stock Titan

Click here to get full coverage on HCW Biologics (NASDAQ: HCWB) turns Q1 profit but flags going concern risk - Stock Titan

HCW Biologics (NASDAQ: HCWB) turns Q1 profit but flags going concern risk  Stock Titan

HCW Biologics (NASDAQ: HCWB) turns Q1 profit but flags going concern risk - Stock Titan

Click here to get full coverage on HCW Biologics (NASDAQ: HCWB) prices $4M private unit financing with warrants - Stock Titan

HCW Biologics (NASDAQ: HCWB) prices $4M private unit financing with warrants  Stock Titan

HCW Biologics (NASDAQ: HCWB) prices $4M private unit financing with warrants - Stock Titan

Click here to get full coverage on HCW Biologics (NASDAQ: HCWB) extends $5.6M offering to May 22, 2026 - Stock Titan

HCW Biologics (NASDAQ: HCWB) extends $5.6M offering to May 22, 2026  Stock Titan

HCW Biologics (NASDAQ: HCWB) extends $5.6M offering to May 22, 2026 - Stock Titan

Click here to get full coverage on HCW Biologics (NASDAQ: HCWB) ends Wugen license, keeps 2.2M shares - Stock Titan

HCW Biologics (NASDAQ: HCWB) ends Wugen license, keeps 2.2M shares  Stock Titan

HCW Biologics (NASDAQ: HCWB) ends Wugen license, keeps 2.2M shares - Stock Titan

Click here to get full coverage on [EFFECT] HCW Biologics Inc. SEC Filing - Stock Titan

[EFFECT] HCW Biologics Inc. SEC Filing  Stock Titan

[EFFECT] HCW Biologics Inc. SEC Filing - Stock Titan

Click here to get full coverage on HCW Biologics Inc. Announces Pricing of Approximately $4.0 - GlobeNewswire

HCW Biologics Inc. Announces Pricing of Approximately $4.0  GlobeNewswire

HCW Biologics Inc. Announces Pricing of Approximately $4.0 - GlobeNewswire

Click here to get full coverage on HCW Biologics (HCWB) Stock Is Trending Overnight — Here's Why It Moved Over 122% In After-Hours Session - Benzinga

HCW Biologics (HCWB) Stock Is Trending Overnight — Here's Why It Moved Over 122% In After-Hours Session  Benzinga

HCW Biologics (HCWB) Stock Is Trending Overnight — Here's Why It Moved Over 122% In After-Hours Session - Benzinga

Click here to get full coverage on HCWB Stock Spikes As Pipeline Data Fuels Biotech Momentum - StocksToTrade

HCWB Stock Spikes As Pipeline Data Fuels Biotech Momentum  StocksToTrade

HCWB Stock Spikes As Pipeline Data Fuels Biotech Momentum - StocksToTrade

Click here to get full coverage on HCW Biologics (HCWB) Posted a Rare Profit, but the Financing Question Is Still Open - AlphaStreet

HCW Biologics (HCWB) Posted a Rare Profit, but the Financing Question Is Still Open  AlphaStreet

HCW Biologics (HCWB) Posted a Rare Profit, but the Financing Question Is Still Open - AlphaStreet

Click here to get full coverage on HCWB Stock Soars As Q1 Profit And Pipeline Fuel Momentum - StocksToTrade

HCWB Stock Soars As Q1 Profit And Pipeline Fuel Momentum  StocksToTrade

HCWB Stock Soars As Q1 Profit And Pipeline Fuel Momentum - StocksToTrade

Click here to get full coverage on HCW Biologics Inc Stock Short Interest Rises to 58.43% - Quiver Quantitative

HCW Biologics Inc Stock Short Interest Rises to 58.43%  Quiver Quantitative

HCW Biologics Inc Stock Short Interest Rises to 58.43% - Quiver Quantitative

Click here to get full coverage on HCW Biologics Inc (HCWB) Institutional Confidence - TradingKey

HCW Biologics Inc (HCWB) Institutional Confidence  TradingKey

HCW Biologics Inc (HCWB) Institutional Confidence - TradingKey

Click here to get full coverage on HCW Biologics Inc (HCWB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

HCW Biologics Inc (HCWB) Financial Health: Profitability & Balance Sheet Analysis  TradingKey

HCW Biologics Inc (HCWB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Click here to get full coverage on HCW Biologics lines up $1.5M, cuts warrant price to $0.6055 - Stock Titan

HCW Biologics lines up $1.5M, cuts warrant price to $0.6055  Stock Titan

HCW Biologics lines up $1.5M, cuts warrant price to $0.6055 - Stock Titan

Click here to get full coverage on HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results - GlobeNewswire

HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results  GlobeNewswire

HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results - GlobeNewswire

Click here to get full coverage on HCW Biologics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

HCW Biologics Disclosed Failure to Satisfy a Continued Listing Rule or Standard  TradingView

HCW Biologics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Click here to get full coverage on HCW Biologics (NASDAQ: HCWB) targets $5.6M primary share and pre-funded warrant offering - Stock Titan

HCW Biologics (NASDAQ: HCWB) targets $5.6M primary share and pre-funded warrant offering  Stock Titan

HCW Biologics (NASDAQ: HCWB) targets $5.6M primary share and pre-funded warrant offering - Stock Titan

Click here to get full coverage on Why Is HCW Biologics Stock Surging On Friday? - Benzinga

Why Is HCW Biologics Stock Surging On Friday?  Benzinga

Why Is HCW Biologics Stock Surging On Friday? - Benzinga

Click here to get full coverage on HCW Biologics Inc (HCWB) Valuation: PE, PB & Fair Value Analysis - TradingKey

HCW Biologics Inc (HCWB) Valuation: PE, PB & Fair Value Analysis  TradingKey

HCW Biologics Inc (HCWB) Valuation: PE, PB & Fair Value Analysis - TradingKey

Click here to get full coverage on HCW Biologics Inc (HCWB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

HCW Biologics Inc (HCWB) Technical Analysis: Support, Resistance, Indicators & Moving Averages  TradingKey

HCW Biologics Inc (HCWB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Click here to get full coverage on Nasdaq panel puts HCW Biologics back in full compliance to raise drug funding - Stock Titan

Nasdaq panel puts HCW Biologics back in full compliance to raise drug funding  Stock Titan

Nasdaq panel puts HCW Biologics back in full compliance to raise drug funding - Stock Titan

Click here to get full coverage on Why HCW Biologics Stock Is Falling On Tuesday? - Benzinga

Why HCW Biologics Stock Is Falling On Tuesday?  Benzinga

Why HCW Biologics Stock Is Falling On Tuesday? - Benzinga

Click here to get full coverage on HCW Biologics Inc (HCWB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

HCW Biologics Inc (HCWB) Dividends & Stock Splits: Historical Payouts and Event Timeline  TradingKey

HCW Biologics Inc (HCWB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Click here to get full coverage on Market Movers | Winners: BCPC, UGRO, MGRX | Losers: AHMA, HCWB, SWMR - Trefis

Market Movers | Winners: BCPC, UGRO, MGRX | Losers: AHMA, HCWB, SWMR  Trefis

Market Movers | Winners: BCPC, UGRO, MGRX | Losers: AHMA, HCWB, SWMR - Trefis

Click here to get full coverage on HCWB Stock Jumps After Licensing Deal But Faces Delisting Risk - timothysykes.com

HCWB Stock Jumps After Licensing Deal But Faces Delisting Risk  timothysykes.com

HCWB Stock Jumps After Licensing Deal But Faces Delisting Risk - timothysykes.com

Click here to get full coverage on Why Is HCW Biologics Stock Surging On Friday? - Sahm

Why Is HCW Biologics Stock Surging On Friday?  Sahm

Why Is HCW Biologics Stock Surging On Friday? - Sahm

Click here to get full coverage on What's Going On With HCW Biologics Stock Monday? - Benzinga

What's Going On With HCW Biologics Stock Monday?  Benzinga

What's Going On With HCW Biologics Stock Monday? - Benzinga

Click here to get full coverage on HCW Biologics Inc (HCWB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

HCW Biologics Inc (HCWB) Earnings Forecast: Future EPS & Revenue Growth Estimates  TradingKey

HCW Biologics Inc (HCWB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Click here to get full coverage on HCW Biologics Inc (HCWB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

HCW Biologics Inc (HCWB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution  TradingKey

HCW Biologics Inc (HCWB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Click here to get full coverage on HCW Biologics Inc (HCWB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

HCW Biologics Inc (HCWB) Risk Assessment: Volatility, Financial Risk & Investment Risk  TradingKey

HCW Biologics Inc (HCWB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Click here to get full coverage on HCWB Maintained by Maxim Group -- Price Target Raised to $5.00 - GuruFocus

HCWB Maintained by Maxim Group -- Price Target Raised to $5.00  GuruFocus

HCWB Maintained by Maxim Group -- Price Target Raised to $5.00 - GuruFocus

Click here to get full coverage on HCW Biologics Inc. Announces Pricing of Private Placement of 2,846,975 Units at $1.405 Each - Quiver Quantitative

HCW Biologics Inc. Announces Pricing of Private Placement of 2,846,975 Units at $1.405 Each  Quiver Quantitative

HCW Biologics Inc. Announces Pricing of Private Placement of 2,846,975 Units at $1.405 Each - Quiver Quantitative

Click here to get full coverage on HCW Biologics Inc (HCWB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

HCW Biologics Inc (HCWB) Shareholder Structure: Major Shareholders & Institutional Holdings  TradingKey

HCW Biologics Inc (HCWB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Click here to get full coverage on HCWB Stock Pops As Rare Disease And Cancer Pipeline Advances - timothysykes.com

HCWB Stock Pops As Rare Disease And Cancer Pipeline Advances  timothysykes.com

HCWB Stock Pops As Rare Disease And Cancer Pipeline Advances - timothysykes.com

Click here to get full coverage on HCW Biologics jumps 309% as traders react to licensing-driven Q1 profit and revenue surge - Quiver Quantitative

HCW Biologics jumps 309% as traders react to licensing-driven Q1 profit and revenue surge  Quiver Quantitative

HCW Biologics jumps 309% as traders react to licensing-driven Q1 profit and revenue surge - Quiver Quantitative

Click here to get full coverage on Keytruda-based shot blocks chronic preemie lung disease in animal test - Stock Titan

Keytruda-based shot blocks chronic preemie lung disease in animal test  Stock Titan

Keytruda-based shot blocks chronic preemie lung disease in animal test - Stock Titan

Click here to get full coverage on What Were HCW Biologics' Key Developments in Q1 2026 - Kavout

What Were HCW Biologics' Key Developments in Q1 2026  Kavout

What Were HCW Biologics' Key Developments in Q1 2026 - Kavout

Click here to get full coverage on HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen - GlobeNewswire

HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen  GlobeNewswire

HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen - GlobeNewswire

Click here to get full coverage on HCW Biologics Announces Positive Research Results for CAR-T - GlobeNewswire

HCW Biologics Announces Positive Research Results for CAR-T  GlobeNewswire

HCW Biologics Announces Positive Research Results for CAR-T - GlobeNewswire

Click here to get full coverage on HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results - Yahoo Finance

HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results  Yahoo Finance

HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results - Yahoo Finance

Click here to get full coverage on Insiders' US$3.05m Investments In Red Following HCW Biologics' US$1.1m Dip In Market Value - simplywall.st

Insiders' US$3.05m Investments In Red Following HCW Biologics' US$1.1m Dip In Market Value  simplywall.st

HCWB

Price Chart

Key Statistics

Technicals

About HCWB

Latest News

HCW Biologics (HCWB) files exhibits-only S-1 amendment with new exhibits - Stock Titan

HCW Biologics (HCWB) Stock Price, News & Analysis - MarketBeat

What's Going On With HCW Biologics Stock Tuesday? - HCW Biologics (NASDAQ:HCWB) - Benzinga

Advanced Charts

Top Gainers

Top Losers